Jlang, Holy smokes, I guess we disagree even more this

New Post Public Reply Private Reply Replies (1) Message Board
CTMedic JLang #102252
523
Jlang,

Holy smokes, I guess we disagree even more this afternoon. However, I'll try to address your claims that I have a "drastically less than complete grasp" of the topic under discussion.

Quote:
Mutation rate isn't moot, it's baseline.. this is about Variants of Concern vs previous variants they're outclassing. For the nth time. They all have roughly the same mutation rate regardless of host.. it's non-relevant with respect to this comparison, not irrelevant in general. You don't comprehend this.


I agree mutation rate isn't moot, though I don't believe that "baseline" is anywhere in the world a synonym for moot. Mutation is the basis from which evolution of variants has the opportunity to occur. Higher mutation rate, equals greater opportunity for change.

I am glad that you finally appreciate that mutations occur roughly at the same rate, irrespective of host immune competence. Until the virus clears (a few weeks in healthy patients, many months in immune compromised patients) viral replication continues with resultant mutations.

Previously you argued:

Quote:
You're approaching it from a mathematical standpoint.. it's not about mutation opportunities, it's about selective pressures. They're uniquely geared towards improving binding affinity and virulence in the immunocompromised.. of which those with HIV are a significant part.


For review, selective pressures are unable to drive development of variants without mutations, some of which may have increased fitness.

Quote:
Again, immune evasion is not the only or I'd argue even the primary selective force for a novel virus.. binding affinity and transmission are of higher relative importance. The strength of the host immune system does matter: in that weaker ones allow the pathogen more time to become familiar and increase binding affinity to the pathogens receptors of choice. This is elementary. You don't comprehend this.


All three characteristics, immune evasion, binding affinity / viral entry and transmission can drive viral fitness.

Immune evasion undoubtedly matters, as improved immune evasion allows covid to persist among a population. This is the crux of the concern that neutralizing antibodies and vaccines will fail to protect.

Weakened host immune response allows continued viral replication, it is unequivocally NOT a selective pressure driving improved binding affinity. The compromised host allows relatively unimpeded viral reproduction, in fact permitting reproduction of "less fit" visions which would be eradicated by a healthy immune system, the exact opposite of what you claim.

I'll try to make this even more simple. Imagine two herd of goats, one living in a valley with enough food and water, but hungry wolves (representing a competent immune system). The goats have an opportunity to reproduce and thrive, but are constantly under attack by wolves. Variation through procreation occurs in these goats, but the presence of the wolves selects for the goats that are the most fleet of foot, wary, and able to reproduce with precocious young (able to run and flee at birth). The eventual result is a population of fast, evasive, and precocious goats.

The second valley, our incompetent immune system, allows the goats to reproduce with just a few lazy third rate goats. Variation among the goats will still occur during reproduction, but without a significant threat from the wolves, the goats remain unchanged without increased wariness, evasion, precious young and accelerated reproduction.The goats, if isolated and separated from predatory threats remain a mixed bag, perhaps even become slower and more slothful (evolution island hypothesis). Only the goats who leave there valley and are tested by wolves and other existential threats will become a more fit variant.

Again compromised host - valley without wolves = mutation opportunity

Valley full of threats = selective pressure

Quote:
A strong, functional host doesn't allow the pathogen the luxury of time to increase binding affinity, as evidenced by the multitude of papers describing weeks-months long, active covid infections in the immunocompromised, with several advantage conferring mutations, with sequential viral samples/references exquisitely building the roadmap of these accumulated mutations... And literally zero of the same detailing a similar process in hosts that have a disease course that lasts for days, max. I've posted several, read them on repeat until it sinks in.
Quote:


I concur that prolonged infection in immunocompromised hosts presents an increased opportunity for mutation and variant emergence. However, immune competent patients still generate very high viral loads, as previously discussed. With high mutation rate, each of the virions, presents a new opportunity for a variant to emerge.

Each virion exists as an independent infective agent, not needing "luxury of time to increase binding affinity." It is either sufficiently fit to bind to the requisite cell surface protein (ACE2, or if it's lucky, a new protein with which it is now able to fuse), enter the cell and reproduce or it is not. Every organism that does not reproduce is an evolutionary dead end.

Please recall RNA virus can explode from a single copy to 100K in 10 hours, with viral loads of 10^12. Again, I concur that immune suppressed patients maintaining high viral titers are an increased opportunity for variant emergence, but so is ongoing infection amongst many millions worldwide.

https://www.researchgate.net/publication/2033...NA_viruses

Quote:
And literally zero of the same detailing a similar process in hosts that have a disease course that lasts for days, max.


Jlang, are your truly arguing that viral mutation only occurs among the immunocompromised?

No viral, bacterial or fungal evolution occurred prior to HIV, chemotherapy and steroids?

Laughable.

Quote:
The immunocompromised allow for mutations in the most crucial of those factors.. for a Novel Virus.. binding affinity to a new species receptor.


I concur, again, that immune compromised patients allow ongoing viral replication and mutation.

Mutation is simply the results of erroneous nucleotide substitution during transcription. Most errors are deleterious, some are neutral and a chance few are advantageous. The advantageous mutations will not reveal themselves, and potentially result in variants, until they emerge and "try their hand" infecting the immune competent, or even more challenging, the immune competent and vaccinated or previously infected.

There is no selective pressure exerted by the weak favoring the strong. Covid virions in immunocompromised patients have already demonstrated the ability to infect via ACE2 or the patient would not be infected. The hurdles for further infection may actually decrease over time in the infected host through syncytia formation.

Quote:
The non-compromised hosts don't have "healthier locks".. they have roughly the same ACE2 receptors as the immunocompromised. The virus has less time trying to pick at ACE2 in a healthy host. Less mutations.. even you can't argue this. And what you don't understand is, this process is iterative and *greater at driving the increase in binding affinity of the viral spike protein and ACE2 in compromised hosts*. The exact opposite of what you're suggesting.


The selective pressures are in fact the opposite of what YOU suggest. A more fit variant is one that is is successful even when "The virus has less time trying to pick at ACE2 in a healthy host."

Ever watched sport competitions? I'm impressed by the contestants on American Ninja Warrior.

Now, if we send a thousand people out of the course and gave them weeks to practice, eventually one will finish. However, who is the better athlete (successful varian), the one who FINALLY prevails or the one who races out of the gate and flashes the course in record time, the first time.

That is your new and dangerous variant.

Don't give up. You'll get it eventually.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IM Cannabis's Third Quarter Financial Jolt

Updated Category News Views 120

IM Cannabis Takes a Hit, But Seeks New Angles Diving into IM Cannabis's (NASDAQ: IMCC) latest financial splash is like reading a weathered old map of the stock market. The third quarter of 2026 wasn't kind to this little cannabis outfit. Revenues have nosedived to C$1.65 million from last year's C$5.08 million. It's not just the typical bad quarter blues; it's a solid...

Continue Reading
MV Transportation Celebrates Leadership Nomination for FTA

Updated Category News Views 102

MV Throws Support Behind Aesch for FTA Role In this wild world where public transit feels the heat from financial burdens, MV Transportation's recent move to support Mark Aesch for the Federal Transit Administration's top spot isn’t just a nod of approval—it's a full-blown trumpet blast. They're not just doling out a basic endorsement here; they're practically waving...

Continue Reading
Enjay Acquires New Method: A Strategic Synergy Unfolds

Updated Category News Views 98

Enjay's Bold Move into New Territory Here's a headline that doesn’t just flutter past like yesterday's news. Enjay Converters Ltd, straight from Cobourg, Ontario, has clinched a deal that looks like it might just shake things up a bit on the food packaging scene. They’ve bagged New Method Packaging LLC, another big player, but this time from the heartland of...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 104

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
Hybrid Bonding Market Shooting to $2.45 Billion by 2033

Updated Category News Views 126

Hybrid Bonding: The Future of Semiconductor Interconnects? Mark these words: Hybrid bonding isn't just another tech trend—it’s morphing into a billion-dollar juggernaut, my friend. With the latest numbers from MarketsandMarkets™, we see a potential leap from USD 0.38 billion in 2026 to a staggering USD 2.45 billion by 2033. We'll be seeing an eye-popping CAGR of...

Continue Reading
Sino Bio Speeds AI Drug Discovery with 4RISE Launch

Updated Category News Views 80

AI Meets Real-World Validation In the world of cutting-edge biotech, Sino Biological is turning heads with its latest move. If you're in the game of AI-driven drug discovery, their new 4RISE™ high-throughput wet-lab validation services could be the breakthrough you've been waiting for. Why? Well, the promise of AI is dazzling, but it all boils down to how fast you can...

Continue Reading
NVIDIA Faces Legal Turbulence: CEO's Exit Sparks Chaos

Updated Category News Views 161

Jensen Huang's Sudden Exit: A Barrage of Headlines In what feels like a blow delivered by a sledgehammer, NVIDIA is rocked by the abrupt resignation of its iconic co-founder and CEO, Jensen Huang. This isn't some quiet departure into the night. Nope, it's more like a cannonball being fired into the investor lounge, leaving a wreckage for all to navigate through. Huang's...

Continue Reading
Nonprofit and Partners Gift Homes to Veterans

Updated Category News Views 87

A Heartfelt Gesture on Veterans Day Now this is the kind of story that gets you right in the gut. On November 9, two veterans, who were likely walking into a golf club thinking it was just another evening, were handed the keys to a future they might have only dreamt of: a mortgage-free home. Operation Finally Home, backed by the big names like Lennar and the patriotic...

Continue Reading
BETR Investors Face Action: Nov. 20 Deadline Nears

Updated Category News Views 121

High Stakes for BETR Shareholders If you're holding shares in Better Home & Finance Holding Company, right now might feel like you're at a craps table with emptying pockets. BETR, trading under NASDAQ, has become the center of a legal hurricane, with investors eyeing the November 20th deadline to join a securities class action led by Hagens Berman. The class period in...

Continue Reading
Philip Scroggie's Legacy in Global Energy Projects

Updated Category News Views 116

A Lifetime of Energy Industry Excellence When you've been around the block in the energy sector as long as Philip D. Scroggie has, you're bound to pick up a few accolades. Recognized as an Inner Circle Lifetime Member, this guy has etched his name in the annals of global energy project management. Yeah, he's been a heavyweight in the oil, gas, and LNG industries, and he's...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting New Indoor Adventure: Albatross to Open Soon

Updated Category News Views 418

Albatross: A New Era in Indoor Entertainment Get ready for an unparalleled experience as Albatross prepares to open its doors, offering a unique blend of indoor mini putting, luxury bowling, craft cocktails, and vibrant dining options. This venue promises to redefine leisure and entertainment as we know it. Grand Opening Celebration Mark your calendars for the grand...

Continue Reading
Navigating Innovation: Key Insights from CIOs Worldwide

Updated Category News Views 179

Understanding the Evolving Role of CIOs The 2025 CIO Report, released by Logicalis, offers invaluable insights gathered from the perspectives of over 1,000 CIOs across the globe. The report highlights a significant shift in the responsibilities of CIOs, revealing that 95% of organizations are making technological investments focused on generating new revenue streams...

Continue Reading
Jake Owen Set to Light Up NASCAR All-Star Race Weekend Concert

Updated Category News Views 447

Exciting Concert Announcement for NASCAR All-Star Race Weekend As part of the thrilling NASCAR All-Star Race weekend, the multi-talented Jake Owen will take the stage on Saturday night as a centerpiece of the festivities. Presented by Raymer Oil, this special performance is eagerly anticipated by both race aficionados and country music fans alike. The event will be held...

Continue Reading
Keros Therapeutics Secures FDA Orphan Drug Designation for KER-065

Updated Category News Views 166

Keros Therapeutics Secures FDA Orphan Drug Designation Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company based in Lexington, has made significant strides in the treatment landscape for Duchenne muscular dystrophy (DMD) by announcing that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug designation for its promising candidate, KER-065....

Continue Reading
AM Best Upholds Credit Ratings for Partners Life Limited

Updated Category News Views 186

AM Best Today Affirms Partners Life Limited's Credit Ratings Recently, AM Best provided a significant update, affirming the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Rating of “a” (Excellent) for Partners Life Limited. These ratings reflect a stable outlook for the company, underscoring its strong financial positioning in the insurance...

Continue Reading